Guardant Health (NASDAQ: GH) Form 144: 2,000 shares listed, 3,000 sold

Rhea-AI Filing Summary

Guardant Health reports a Form 144 filing listing 2,000 shares to be sold. The filing names Charles Schwab & Co., Inc. as the broker and records a prior sale of 3,000 shares on 03/16/2026.

The shares are described as tied to a Performance Stock Lapse from 02/01/2025

Insights

Securities Attorney

Routine resale notice under Rule 144; no material corporate action disclosed.

The filing lists 2,000 shares available to sell and notes a prior sale of 3,000 shares on 03/16/2026. It names Charles Schwab & Co., Inc. as the broker and cites an equity compensation source.

These entries are administrative disclosures required for resale; cash‑flow treatment and pricing are not included in the excerpt. Subsequent filings would show consummated transactions or pricing details.

Key Figures

Shares listed to be sold: 2,000 shares Shares sold in past 3 months: 3,000 shares Broker: Charles Schwab & Co., Inc.

3 metrics

Shares listed to be sold 2,000 shares Securities To Be Sold; <date>02/01/2025</date>

Shares sold in past 3 months 3,000 shares Securities Sold During The Past 3 Months; <date>03/16/2026</date>

Broker Charles Schwab & Co., Inc. Broker listed for proposed sale; Westlake TX address

Key Terms

Form 144, Performance Stock Lapse, Equity Compensation

3 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Performance Stock Lapse financial

"Common | 02/01/2025 | Performance Stock Lapse | GUARDANT HEALTH, INC."

Equity Compensation financial

"02/01/2025 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/05/2026 - 04:03 PM Accepted by SEC EDGAR 06/05/2026 - 04:02 PM Learn about SEC filing dates

FAQ

What does Guardant Health's (GH) Form 144 report?

It reports a proposed sale listing 2,000 shares to be sold. The filing names Charles Schwab & Co., Inc. as the broker and ties the shares to a Performance Stock Lapse dated 02/01/2025.

Was there recent selling activity disclosed for GH insiders?

Yes, the excerpt records a prior sale of 3,000 shares on 03/16/2026. That transaction appears under "Securities Sold During The Past 3 Months." The filing does not provide sale price or proceeds information.

Who is the broker handling the proposed sale in the Form 144?

The broker listed is Charles Schwab & Co., Inc. at the Westlake, TX address. The filing shows the broker name and contact line but does not state execution timing or pricing details.

Are the shares described as compensation-related for GH?

Yes, the filing ties the listed shares to Equity Compensation and specifically a Performance Stock Lapse dated 02/01/2025. The excerpt does not state vesting outcomes or cash proceeds from any sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	2000	257241.00	132599929	06/05/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/01/2025	Performance Stock Lapse	GUARDANT HEALTH, INC.			2000	02/01/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Brian Bell 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	03/16/2026	3000	261111.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)